Latest Breaking News On - Welldoc bluestar - Page 3 : comparemela.com
Prescription Digital Therapeutics (PDTx) Market 2021 – Industry Share, Growth, Trends Analysis Report – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.
(Image: Screenshot of the Glooko.com website)
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup s app-based platform acts as a central hub for connected monitoring devices and other disease-relevant data streams. Users, for instance, can import the data from their glucose meter or CGM. (The company claims to be compatible with 95% of all diabetes devices.)
Then they view those readings alongside their meal logs or activity data collected through third-party fitness platforms like Fitbit or Strava. Users can also review educational resources or follow care programs tracked by the app, and export all of their data for review by their doctor.
Covid-19 has laid bare crippling interoperability issues.
Memeburn ~ Sam Spiller ~ 03/03/2021
The app allows officials to scan a QR code on the traveller’s phone to check if they have been tested or vaccinated.
AP ~ Frank Jordans ~ 04/03/2021
“There are historical reasons why we don’t have a centralised register like in Denmark,” said von Gaudecker, citing Germany’s grim history of state oppression under Nazism and communism.
The Connexion ~ Hannah Thompson ~ 04/03/2021
Mr Macron said that it would be intended to hold a record of recent negative Covid tests, and would also show if the holder had been vaccinated.
Digital Health News ~ Andrea Downey ~ 04/03/2021
Eli Lilly, Welldoc collaborate on new version of BlueStar platform
mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Senior Editor
Management of Type 1 and Type 2 diabetes is going high tech, thanks to a collaboration between Welldoc and Eli Lilly. The companies are partnering to integrate Welldoc s software into Lilly s connected insulin solutions, currently in development.
Under the terms of the agreement, Lilly and Welldoc will collaborate to create a new version of the BlueStar insulin management solution that integrates insulin dosing data for several Lilly insulins. Lilly will commercialize the pen platform, which will include the new app and Lilly s connected insulin pen solutions.
Welldoc s BlueStar app is a digital health solution cleared by the Food and Drug Administration for use by adults with Type 1 or Type 2 diabetes. The app has both prescription and non-prescription features such as insulin titration support, a bolus calculator and personalized health coaching, and integrates blood glucose monitoring and continuous glucose monitoring for people who use insulin.
vimarsana © 2020. All Rights Reserved.